Completely automated, highly error-tolerant macromolecular structure determination from multidimensional nuclear overhauser enhancement spectra and chemical shift assignments

Journal of the American Chemical Society

Volumn 126, Issue 20, 2004, Pages 6258-6273

  Kuszewski, John ^a   Schwieters, Charles D ^a   Garrett, Daniel S ^b   Byrd, R Andrew ^c   Tjandra, Nico ^d   Clore, G Marius ^b  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

^d NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALGORITHMS; DATA REDUCTION; ERROR ANALYSIS; INFORMATION ANALYSIS; NUCLEAR MAGNETIC RESONANCE; ROBUSTNESS (CONTROL SYSTEMS);

DATASETS; MACROMOLECULAR STRUCTURE; NUCLEAR OVERHAUSER ENHANCEMENT (NOE); REACTIVATION;

PROTEINS;

BACTERIAL PROTEIN; CYANOVIRIN N; GUANINE NUCLEOTIDE BINDING PROTEIN; INTERLEUKIN 4; STREPTOCOCCAL PROTEIN G; UNCLASSIFIED DRUG;

ALGORITHM; ARTICLE; AUTOMATION; IMAGE RECONSTRUCTION; MACROMOLECULE; NUCLEAR OVERHAUSER EFFECT; PROTEIN ANALYSIS; PROTEIN B1 DOMAIN; PROTEIN DOMAIN; PROTEIN FOLDING; PROTEIN STRUCTURE; PROTON NUCLEAR MAGNETIC RESONANCE; PUBLICATION; STREPTOCOCCUS; STRUCTURE ANALYSIS; THREE DIMENSIONAL IMAGING;

ALGORITHMS; BACTERIAL PROTEINS; COMPUTER SIMULATION; DATA INTERPRETATION, STATISTICAL; INTERLEUKIN-4; MAGNETIC RESONANCE SPECTROSCOPY; MODELS, MOLECULAR; MODELS, STATISTICAL; MOLECULAR CONFORMATION; PROTEINS;

EID: 2442717620     PISSN: 00027863     EISSN: None     Source Type: Journal    
DOI: 10.1021/ja049786h     Document Type: Article

References (68)

1. Tjandra, N.; Bax, A. Science 1997, 278, 1111-1114.
2. (b) Clore, G. M.; Starich, M. R.; Gronenborn, A. M. J. Am. Chem. Soc. 1998, 120, 10571-10572.
3. (c) Hansen, M. R.; Mueller, L.; Pardi, A. Nat. Struct. Biol. 1998, 5, 1065-1074.
4. (d) Prestegard, J. J.; Al-Hashimi, H. M.; Tolman, J. R. Q. Rev. Biophys. 2000, 33, 371-424.
5. (e) Bax, A.; Kontaxis, G.; Tjandra, N. Methods Enzymol. 2001, 339, 127-174.
6. (a) Clore, G. M.; Starich, M. R.; Bewley, C. A.; Cai, M.; Kuszewski, J. J. Am. Chem. Soc. 1999, 121, 6513-6514.
7. (b) Clore, G. M. Proc. Natl. Acad. Sci. U.S.A. 1998, 97, 9021-9025.
8. (c) Fowler, C. A.; Tian, F.; Al-Hashimi, H. M.; Prestegard, J. H. J. Mol. Biol. 2000, 304, 447-460.
9. (a) Delaglio, F.; Kontaxis, G.; Bax, A. J. Am. Chem. Soc. 2000, 122, 2142-2143.
10. (b) Hus, S. C.; Marion, D.; Blackledge, M. J. Am. Chem. Soc. 2001, 123, 1541-1542.
11. (c) Rohl, C.; Baker, D. J. Am. Chem. Soc. 2002, 124, 2723-2729.
12. (d) Clore, G. M.; Schwieters, C. D. J. Am. Chem. Soc. 2003, 125, 2902-2912.
13. Wüthrich, K. NMR of Proteins and Nucleic Acids; Wiley: New York, 1986.
14. (a) Clore, G. M.; Gronenborn, A. M. Protein Eng. 1987, 1, 275-288.
15. (b) Clore, G. M.; Gronenborn, A. M. Crit. Rev. Biochem. Mol. Biol. 1989, 24, 479-564.
16. Clore, G. M.; Gronenborn, A. M. Proc. Natl. Acad. Sci. U.S.A. 1998, 95, 5891-5898.
17. (a) Clore, G. M.; Gronenborn, A. M. Science 1991, 252, 1390-1399.
18. (b) Bax, A.; Grzesiek, S. Acc. Chem. Res. 1993, 26, 131-138.
19. (c) Cavanagh, J.; Fairbrother, W. J.; Palmer, A. J., III; Skelton, N. J. Protein NMR Spectroscopy: Principles and Practice; Academic Press: New York, 1996.
20. (a) Kraulis, P. J.; Clore, G. M.; Nilges, M.; Jones, T. A.; Petersson, G.; Knowles, J.; Gronenborn, A. M. Biochemistry 1989, 28, 7241-7257.
21. (b) Mumenthaler, C.; Braun, W. J. Mol. Biol. 1995, 254, 465-480.
22. (c) Mumenthaler, C.; Güntert, P.; Braun, W.; Wüthrich, K. J. Biomol. NMR 1997, 10, 351-362.
23. (d) Hare, B. J.; Wagner, G. J. Biomol. NMR 1999, 15, 103-113.
24. Duggan, B. M.; Legge, G. B.; Dyson, H. J.; Wright, P. E. J. Biomol. NMR 2001, 19, 321-329.
25. Garrett, D. S.; Powers, R.; Gronenborn, A. M.; Clore, G. M. J. Magn. Reson. 1991, 95, 214-220.
26. (a) Kleywegt, G. J.; Boelens, R.; Kaptein, R. J. Magn. Reson. 1990, 88, 601-608.
27. Antz, C.; Come, S. A.; Johnson, P. Neural Networks 1992, 6, 1023-1032.
28. (b) Neidig, K. P.; Kalbitzer, H. R. J. Biomol. NMR 1995, 5, 287-296.
29. (c) Koradi, R.; Billeter, M.; Engeli, M.; Güntert, P.; Wüthrich, K. J. Magn. Reson. 1998, 135, 288-297.
30. (a) Nilges, M. J. Mol. Biol. 1995, 245, 645-660.
31. (b) Nilges, M.; Macias, M. J.; O'Donoghue, S. I.; Oschkinat, H. J. Mol. Biol. 1997, 269, 408-422.
32. (c) Nilges, M. Folding Des. 1997, 2, S53-S57.
33. (d) Pascual, M.; Linge, J. P.; O'Donoghue, S. I.; Nilges, M. Methods Enzymol. 2001, 339, 71-90.
34. (e) Longe, J. P.; Habeck, M.; Rieping, W.; Nilges, M. Bioinformatics 2003, 19, 315-316.
35. (a) Hermann, T.; Güntert, P.; Wüthrich, K. J. Mol. Biol. 2002, 319, 209-227.
36. (b) Herrmann, T.; Güntert, P.; Wüthrich, K. J. Biomol. NMR 2002, 24, 171-189.
37. Güntert, P. Prog. Nucl. Magn. Reson. Spectrosc. 2003, 43, 105-125.
38. Nilges, M. Proteins 1993, 17, 297-309.
39. Nilges, M.; Gronenborn, A. M.; Brünger, A. T.; Clore, G. M. Protein Eng. 1988, 2, 27-38.
40. Jee, J. G.; Güntert, P. J. Struct. Funct. Genomics 2003, 4, 179-189.
41. Schwieters, C. D.; Kuszewski, J.; Tjandra, N.; Clore, G. M. J. Magn. Reson. 2003, 121, 65-73.
42. (a) Powers, R.; Garrett, D. S.; March, C. J.; Frieden, E. A.; Gronenborn, A. M.; Clore, G. M. Biochemistry 1992, 31, 4334-4346.
43. (b) Garrett, D. S.; Powers, R.; March, C. J.; Frieden, E. A.; Clore, G. M.; Gronenborn, A. M. Biochemistry 1992, 31, 4347-4353.
44. (c) Powers, R.; Garrett, D. S.; March, C. J.; Frieden, E. A.; Gronenborn, A. M.; Clore, G. M. Science 1992, 256, 1673-1677.
45. (d) Powers, R.; Garrett, D. S.; March, C. J.; Frieden, E. A.; Gronneborn, A. M.; Clore, G. M. Biochemistry 1993, 32, 6744-6762.
46. Bewley, C. A.; Gustafson, K. R.; Boyd, M. R.; Covell, D. G.; Bax, A.; Clore, G. M.; Gronenborn, A. M. Nat. Struct. Biol. 1998, 5, 571-578.
47. (a) Gronenborn, A. M.; Filpula, D. R.; Essig, N. Z.; Achari, A.; Whitlow, M.; Wingfield, P. T.; Clore, G. M. Science 1991, 253, 657-661.
48. (b) Kuszewski, J.; Gronenborn, A. M.; Clore, G. M. J. Am. Chem. Soc. 1999, 121, 2337-2338.
49. Abramowitz, M.; Stegun, I. A. Handbook of Mathematical Functions with Formulas, Graphs, and Mathematical Tables, 9th printing; Dover: New York, 1972; p 1020.
50. Metropolis, N.; Rosenbluth, A. W.; Rosenbluth, J. H.; Teller, A. H.; Teller, E. J. Chem. Phys. 1953, 21, 1087-1092.
51. Given that only a single NOE assignment is active at any point in time during pass 3, the question arises as to how to best treat the target distance in eq 3 in cases where a single NOE cross-peak arises from genuine overlap of two or more NOE interactions. Our choice is to leave the target distance unaltered, because, in most cases, cross-peaks do arise from only a single NOE interaction. If a cross-peak genuinely arises from say two NOE interactions of approximately equal intensity, this will be directly reflected in the final likelihoods computed by the PASD algorithm (see section on Final Assignment and Restraints Likelihoods). The distance correction to the upper distance bound for two equally probable assignments would be 12% at most (corresponding to a reduction by a factor of 2 in NOE intensity). However, because the NOE intensities are converted into loose distance ranges, such a correction, in the context of the PASD calculations, is unnecessary. If, on the other hand, the contribution of one of the two NOE interactions constitutes only a very small proportion of the NOE cross-peak intensity, and the NOE restraint associated with that cross-peak is classified as strong, then the weaker interaction would be excluded by the probabilistic inactivation mechanism employed by the PASD algorithm, with no untoward effect.
52. Clore, G. M.; Nilges, M.; Sukuraman, D. K.; Brünger, A. T.; Karplus, M.; Gronenborn, A. M. EMBO J. 1986, 5, 2729-2735.
53. Cornilescu, G.; Delaglio, F.; Bax, A. J. Biomol. NMR 1999, 13, 289-302.
54. (a) Kuszewski, J.; Gronenbom, A. M.; Clore, G. M. Protein Sci. 1996, 5, 1067-1080.
55. (b) Clore, G. M.; Kuszewski, J. J. Am. Chem. Soc. 2002, 124, 2866-2867.
56. 0.38, where N is the number of residues included in the structure determination (ref 20b).
57. Schwieters, C. D.; Clore, G. M. J. Magn. Reson. 2001, 152, 288-302.
58. A "good" TALOS prediction is defined as follows: either all 10 best database matches for that residue fall in a consistent region of the Ramachandran map, or 9 out of the 10 best database matches fall in a consistent region with φ < 0, and the one outlier also lies in the φ < 0 half of the Ramachandran map (cf. ref 25).
59. Schwieters, C. D.; Clore, G. M. J. Magn. Reson. 2001, 149, 239-244.
60. Clore, G. M.; Gronenborn, A. M.; Nilges, M.; Ryan, C. A. Biochemistry 1987, 26, 8012-8023.
61. Gallagher, T.; Alexander, P.; Bryan, P.; Gilliland, G. L. Biochemistry 1994, 33, 4721-4729.
62. Wlodawer, A.; Pavlosky, A.; Gustchina, A. FEBS Lett. 1992, 309, 59-64.
63. Yang, F.; Bewley, C. A.; Louis, J. M.; Gustafson, K. R.; Boyd, M. R.; Gronenborn, A. M.; Clore, G. M.; Wlodawer, A. J. Mol. Biol. 1999, 288, 403-412.
64. Chou, J. J.; Case, D. A.; Bax, A. J. Am. Chem. Soc. 2003, 125, 8959-8966.
65. A missing resonance assignment can have two possible consequences with regard to the generation of NOE assignments. If a particular NOE cross-peak cannot be assigned to any pairwise interaction due to a missing resonance assignment, the effect is entirely neutral because no incorrect information is incorporated into the NOE restraints list. If, on the other hand, a given NOE cross-peak has multiple possible assignments, because of chemical shift degeneracy, and the resonance assignment for one of the partners for the correct NOE assignment is absent, the resulting NOE restraint (which may comprise multiple possible NOE assignments) will be incorrect.
66. Nabuurs, S. B.; Spronk, C. A. E. M.; Krieger, H.; Maasen, G. H.; Vriend, G.; Vuister, G. W. J. Am. Chem. Soc. 2003, 125, 12026-12034.
67. (a) Bewley, C. A.; Clore, G. M. J. Am. Chem. Soc. 2000, 122, 6009-6016.
68. (b) Barrientos, L. G.; Louis, J. M.; Botos, I.; Mori, T.; Han, Z.; O'Keefe, B. R.; Boyd, M. R.; Wlodawer, A.; Gronenborn, A. M. Structure 2002, 10, 673-686.